Principal Securities’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,000
Closed -$15.5K 3280
2025
Q3
$15.5K Sell
2,000
-195
-9% -$1.52K ﹤0.01% 2531
2025
Q2
$19.1K Buy
2,195
+23
+1% +$167 ﹤0.01% 2341
2025
Q1
$19.7K Hold
2,172
﹤0.01% 2200
2024
Q4
$19.7K Sell
2,172
-9
-0.4% -$87 ﹤0.01% 2197
2024
Q3
$20K Sell
2,181
-77
-3% -$637 ﹤0.01% 2124
2024
Q2
$22.1K Buy
2,258
+157
+7% +$1.92K ﹤0.01% 2023
2024
Q1
$31.7K Buy
2,101
+1
+0% +$18 ﹤0.01% 1770
2023
Q4
$45.3K Buy
+2,100
New +$38.7K ﹤0.01% 1535

Other funds holding TDOC

Principal Securities's TDOC Position: Q4 2025 in Review

Principal Securities sold out of Teladoc Health (TDOC) in Q4 2025, closing a stake of 2,000 shares — an estimated $15.5K sold.

Principal Securities first reported a position in TDOC in Q4 2023 and held it in 8 quarters. The position peaked at $45.3K in Q4 2023. 344 funds tracked by Wall St. Rank hold TDOC as of Q4 2025.

  • Principal Securities reported no remaining Teladoc Health position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 2,000 Teladoc Health shares in Q4 2025, an estimated $15.5K.
  • Principal Securities first reported a position in Teladoc Health in Q4 2023 and held it in 8 quarters.
  • Principal Securities's Teladoc Health position peaked at $45.3K in Q4 2023.
  • 344 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.